Cargando…
High glucose induces podocyte epithelial-to-mesenchymal transition by demethylation-mediated enhancement of MMP9 expression
Abnormal expression of matrix metalloproteinase 9 (MMP9) is correlated with podocyte epithelial-to-mesenchymal transition (EMT) in diabetic nephropathy (DN). However, the mechanisms underlying this process are not well defined. Site-specific demethylation may sustain high expression levels of target...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866005/ https://www.ncbi.nlm.nih.gov/pubmed/29436620 http://dx.doi.org/10.3892/mmr.2018.8554 |
_version_ | 1783308792043143168 |
---|---|
author | Ling, Li Chen, Libo Zhang, Changning Gui, Shuyan Zhao, Haiyan Li, Zhengzhang |
author_facet | Ling, Li Chen, Libo Zhang, Changning Gui, Shuyan Zhao, Haiyan Li, Zhengzhang |
author_sort | Ling, Li |
collection | PubMed |
description | Abnormal expression of matrix metalloproteinase 9 (MMP9) is correlated with podocyte epithelial-to-mesenchymal transition (EMT) in diabetic nephropathy (DN). However, the mechanisms underlying this process are not well defined. Site-specific demethylation may sustain high expression levels of target genes. In the present study, in order to investigate the association between DNA demethylation of MMP9 promoter and podocyte EMT in DN, human podocytes were cultured in high-glucose (HG) medium and a rat model of DN was established by intraperitoneal injection of streptozotocin (STZ) to determine whether site-specific demethylation of the MMP9 promoter was involved in regulating podocyte EMT in DN. The MTT assay was used to assess the effects of HG culture on the growth of podocytes, and the demethylation status of the MMP9 promoter was assessed by bisulfite sequencing polymerase chain reaction. mRNA and protein expression levels of MMP9, α-smooth muscle actin (α-SMA), podocalyxin and fibronectin-1 in podocytes were assessed by reverse transcription-quantitative PCR (RT-qPCR) and western blot analyses. The results demonstrated that HG treatment up regulated the expression of MMP9, α-SMA and fibronectin-1, but down regulated the expression of podocalyxin in podocytes. The MMP9 promoter region was revealed to contain a variety of demethylated CpG sites, and HG treatment reduced the rate of MMP9 promotermethylation, which, in turn, enhanced its promoter activity. In summary, these data suggested that demethylation of the MMP9 promoter may serve an important role in podocyte EMT in DN. The demethylation status of the MMP9 promoter maybe used as an important prognostic marker of DN in clinic. |
format | Online Article Text |
id | pubmed-5866005 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-58660052018-03-28 High glucose induces podocyte epithelial-to-mesenchymal transition by demethylation-mediated enhancement of MMP9 expression Ling, Li Chen, Libo Zhang, Changning Gui, Shuyan Zhao, Haiyan Li, Zhengzhang Mol Med Rep Articles Abnormal expression of matrix metalloproteinase 9 (MMP9) is correlated with podocyte epithelial-to-mesenchymal transition (EMT) in diabetic nephropathy (DN). However, the mechanisms underlying this process are not well defined. Site-specific demethylation may sustain high expression levels of target genes. In the present study, in order to investigate the association between DNA demethylation of MMP9 promoter and podocyte EMT in DN, human podocytes were cultured in high-glucose (HG) medium and a rat model of DN was established by intraperitoneal injection of streptozotocin (STZ) to determine whether site-specific demethylation of the MMP9 promoter was involved in regulating podocyte EMT in DN. The MTT assay was used to assess the effects of HG culture on the growth of podocytes, and the demethylation status of the MMP9 promoter was assessed by bisulfite sequencing polymerase chain reaction. mRNA and protein expression levels of MMP9, α-smooth muscle actin (α-SMA), podocalyxin and fibronectin-1 in podocytes were assessed by reverse transcription-quantitative PCR (RT-qPCR) and western blot analyses. The results demonstrated that HG treatment up regulated the expression of MMP9, α-SMA and fibronectin-1, but down regulated the expression of podocalyxin in podocytes. The MMP9 promoter region was revealed to contain a variety of demethylated CpG sites, and HG treatment reduced the rate of MMP9 promotermethylation, which, in turn, enhanced its promoter activity. In summary, these data suggested that demethylation of the MMP9 promoter may serve an important role in podocyte EMT in DN. The demethylation status of the MMP9 promoter maybe used as an important prognostic marker of DN in clinic. D.A. Spandidos 2018-04 2018-02-02 /pmc/articles/PMC5866005/ /pubmed/29436620 http://dx.doi.org/10.3892/mmr.2018.8554 Text en Copyright: © Ling et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Ling, Li Chen, Libo Zhang, Changning Gui, Shuyan Zhao, Haiyan Li, Zhengzhang High glucose induces podocyte epithelial-to-mesenchymal transition by demethylation-mediated enhancement of MMP9 expression |
title | High glucose induces podocyte epithelial-to-mesenchymal transition by demethylation-mediated enhancement of MMP9 expression |
title_full | High glucose induces podocyte epithelial-to-mesenchymal transition by demethylation-mediated enhancement of MMP9 expression |
title_fullStr | High glucose induces podocyte epithelial-to-mesenchymal transition by demethylation-mediated enhancement of MMP9 expression |
title_full_unstemmed | High glucose induces podocyte epithelial-to-mesenchymal transition by demethylation-mediated enhancement of MMP9 expression |
title_short | High glucose induces podocyte epithelial-to-mesenchymal transition by demethylation-mediated enhancement of MMP9 expression |
title_sort | high glucose induces podocyte epithelial-to-mesenchymal transition by demethylation-mediated enhancement of mmp9 expression |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866005/ https://www.ncbi.nlm.nih.gov/pubmed/29436620 http://dx.doi.org/10.3892/mmr.2018.8554 |
work_keys_str_mv | AT lingli highglucoseinducespodocyteepithelialtomesenchymaltransitionbydemethylationmediatedenhancementofmmp9expression AT chenlibo highglucoseinducespodocyteepithelialtomesenchymaltransitionbydemethylationmediatedenhancementofmmp9expression AT zhangchangning highglucoseinducespodocyteepithelialtomesenchymaltransitionbydemethylationmediatedenhancementofmmp9expression AT guishuyan highglucoseinducespodocyteepithelialtomesenchymaltransitionbydemethylationmediatedenhancementofmmp9expression AT zhaohaiyan highglucoseinducespodocyteepithelialtomesenchymaltransitionbydemethylationmediatedenhancementofmmp9expression AT lizhengzhang highglucoseinducespodocyteepithelialtomesenchymaltransitionbydemethylationmediatedenhancementofmmp9expression |